Abstract
Immune rejection hinders the application of human embryonic stem cells (hESCs) in transplantation therapy. Human leukocyte antigens (HLAs) on the cell surface are the major cause of graft rejection. In this study, we generatedHLA class I-deficient hESCs via disruption of beta 2-microglobulin (β2m), the light chain of HLA Class I. We found that HLA class I proteins were not present on the cell surface of β2mnull hESCs. These cells showed the same pluripotency as wildtype hESCs and demonstrated hypoimmunogenicity. Thus, HLA class I-deficient hESCs might serve as an unlimited cell source for the generation of universally compatible “off-the-shelf” cell grafts, tissues or organs in the future.
| Original language | English (US) |
|---|---|
| Article number | A007 |
| Pages (from-to) | 806-813 |
| Number of pages | 8 |
| Journal | Stem Cell Reviews and Reports |
| Volume | 9 |
| Issue number | 6 |
| DOIs | |
| State | Published - Dec 2015 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Beta 2-microglobulin
- Human embryonic stem cells
- Human leukocyte antigens
- Hypoimmunogenicity
- IPS cells
- Immune rejection
ASJC Scopus subject areas
- Cell Biology
- Cancer Research
Fingerprint
Dive into the research topics of 'Generating hypoimmunogenic human embryonic stem cells by the disruption of beta 2-microglobulin'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS